Insilico pharmacological evaluation of dibenzosuberenone derivatives as antidepressant

Abstract

A new drug takes a long time and is expensive to introduce.By using insilico drug design, you can save time and money. Utilizing computational software, a novel Schiff's base Dibenzosuberenone derivative was designed and molecular docking studies were performed using autodock software. To predict Absorption, Distribution, Metabolism, Excretion, and Molecular Properties of Dibenzosuberenone derivatives, insilico screening was performed. It should be examined how its Dibenzosuberenone derivatives interact with specific targets. The Dibenzosuberenone derivatives were successfully identified as targets in this study.